INTRODUCTION
Of all chronic pain disorders, chronic low back ache is the most common. 1 Chronic low back ache is defined as chronic and recurrent pain persistent for more than 3 months as most of the connective tissues heal normally in one half to three months period, unless there is any pathoanatomic instability. Chronic low back ache is the most widely recognized of all spinal, and even endless, pain issues. Any pathology in lumbar spine vertebrae, interarticular joints, sacroiliac joints, tendons, ligaments, muscles, and nerve root dura may prompt pain in the lumbar spine with symptoms of back ache in lumboscaral region and lower limb.
Frequently, the correct reason for the pain can't be found. Proof demonstrate that lumabr facet joint pain represent 30% of cases, sacroiliac joint pain represents under 10% of cases, and diagnostic pain represents 25% of the patients with unending low back pain without disc prolapse or narrowing of the spinal canal.
In a meta-analysis of available data in regards to the frequency and relationship of persistent pain in the elderly population is 56%. 2 In a cross sectional investigation in Korea the existence time of low back ache in patients with high blood pressure was 54.4%. 3 Multiple therapeutic interventional techniques for chronic low back ache with reasonable evidence exists.
1 Facet joint injection with steroids in combination with local anesthetic is one of the safe minimally invasive treatments for this purpose. 4 Studies have shown significant improvement in patients, symptoms on numerical rating pain scale (NRS). 5 Intraarticular combination of triamcinolone and lignocaine in facet joint is a treatment modality for low back ache that originates from facet joint and had adequate immediate and constant effect. 6 In lumber spinal stenosis patients facet joint injection is an effective treatment having 59.5% efficacy. 7 The present study will help in establishing local statistics on effectiveness of steroid in combination with lignocaine in our population as different authors have reported different results and also no single study has been conducted in our community on outcome of facet joint steroid injection in combination with local anesthetic for chronic low back ache. This will helps us in reducing the cost of treatment and frequent Outpatient Department (OPD) visits associated with for chronic low back ache. The results of this study will be disseminated to other health professionals and suggestions will be given for rational use for steroid injection for chronic low back ache.
METHODS
This descriptive study was conducted in the Post Graduate Department of Orthopedics GMC Srinagar Kashmir from June 2016 to September 2017. Pain which occurs in an area with boundaries between the lower rib and the crease of the buttocks is low back ache persistent for three months or more or, despite treatment of back ache having known pathology. Patients of either gender with age ranged 18-70 years having back pain and poor response to NSAIDS and persistent for more than three months were included in the study. Pregnant ladies, low back ache secondary to fracture vertebrae, tumor, inflammatory disorder, infection, any disease that need immediate surgical intervention were not included in our study. Prior permission of the study from Ethical Review Board was taken. Informed consent was taken from all the participants of the study. Nonprobability consecutive sampling technique was used for sampling.
The sample size of our study was 100, using available evidence of 59.5% excellent outcome of facet joint injection for chronic low back ache in literature, 95% confidence interval and 8% error margin and formula adopted was WHO health statistic sample size formula. Measurement tool used for outcome of pain relief was visual analogue scale (VAS). The patients were asked to rate their pain intensity on a 10-point scale before and after treatment at specific intervals. VAS scale 0 indicates no pain and 10 indicate severe pain within 1 week, interpreted as 0: none; 1, 2, 3: mild; 4, 5, 6: moderate 7, 8, 9, 10: severe. Treatment was considered effective if the patient score below 4 on VAS after treatment with facet joint steroid.
In all the included subjects clinical assessment including history and clinical examination and radiograph of the affected site and explanation of the procedure itself. They were admitted for short stay admission.
Prior to the procedure the patients were assessed using visual analog scale (VAS) for grading of low back pain. Following up were done at six weeks, time and improvement was measured using the same grading system to confirm the effectiveness of the procedure.
Injection was administered under image intensifier. Patient position was 45 degree prone with soft padding under abdomen. After facet joint is identified, needle is advanced under image guidance till bone is felt under aseptic conditions. Each facet joint was be infiltrated with a mixture containing 10 mg of steroid and 2 ml of 1% lidocaine.
All information was recorded in a specially design proforma. Strict exclusion criteria was followed in order to control study bias and confounders. All the procedures and follow up was conducted by a single experienced surgeon.
All data was stored and analyzed using SPSS version 17. Quantitative variables like age, duration of back ache was analyzed using mean along with standard deviation (before and after treatments). Qualitative variable like gender, pain intensity, efficacy were analyzed using frequency and percentage. In order to assess the effect of age, duration of LBP, and gender on efficacy, data was stratified with respect to age, gender, duration of back ache, pain before treatment. Chi-square test was applied after stratification. P value was kept ≤0.05 as significant.
RESULTS
Study was performed in the Orthopaedic Department GMC, Srinagar, Kashmir. Total number of patients was 100.Distribution of 100 patients in age ranges were 19% patients were between 20-40 years, 54%patients were between 41-60 years and 27% patients were between 61-70 years. Average age was 56 years with SD ±22.91. Gender distribution among 100 patients was analyzed as 52% male and48%female. Majority (58%) of the patients had low back pain ≤10 months while 42% patients had low back pain >10 months. Mean duration of low back pain was 8 month with SD ±3.37. About 68% patients had moderate pain with VAS pain score (4-6) while 32%patients had severe pain with VAS pain score (7-10) before the injection. Mean pre injection pain score was 7 with SD ±3.82. VAS pain score and severity of low back pain after the treatment showed that 18% patients had no pain with VAS pain score (0), 49% patients had mild pain with VAS pain score (1-3) and 33%patients had moderate pain with VAS pain score (4) (5) (6) . Mean post injection pain score was 3 with SD ±1.97. Facet joint steroid injection effectiveness was observed in 67% patients and ineffective in 33% patients.
Age, gender and duration of low back ache stratification with respect to effectiveness are given in tables (Table 1 -3 respectively). No statistically significance was noted by analyzing these three variables (p=0.9121, 0.9514 and 0.9449 respectively). 
DISCUSSION
Chronic low back ache is the most frequent of all spinal problems, and even persistent pain problems. Any pathology in lumber spine, articular facet joints, sacroiliac joints, ligaments, fascia, muscles, and nerve root dura may lead to pain in the lumbar spine with resulting symptoms of low back pain and pain radiating to lower limb. Often, the exact cause of the pain cannot be found. In literature the frequency of patients with facet pain is 30%, sacroiliac joint pain less than 10%, and that of diagnostic pain 25% of the patients with chronic low back ache without disc prolapse or narrowing of the spinal canal. 9 Our study shows that mean age was 56 years with SD ±22.91. 52% patients were male while forty-eight percent patients were female. Mean duration of low back ache was 8 month with SD ±3.37. Moreover facet joint steroid injection in combination with lignocaine was efficacious in 67% patients and was not effective in 33% patients.
Similar results were observed in another study conducted by Hwang et al that included 42 enrolled patients (male/female=14/28; mean age, 58 years; range, 41-88 years), 25 patients (59.5%) were labelled as having favorable outcome while 17 patients were labelled unfavorable outcome. 10 Eighteen (72%) of the 25 patients with mild-to-moderate spinal canal narrowing had effective relied relief, and 7 of the 17 (41.2%) patients with severe central canal narrowing had effective relief.
Similarly, in Shah et al research study, 20 to 70 years age group had no relief of low back ache with conventional oral analgesic and exercises. 11 The facet joint were injected under image intensifier. Pain was analyzed using Mac nab and Prolo pain assessment criteria. Additional data, including short-term effect (>1 week) and mediumterm effect (at 3 months), were collected by a structured review interview. Results of different radiological investigations done in these patients were noted. Low back ache was relieved in 37 patients (74%) and 28 (56%) patients immediately (7 days) and short term (one and half months) respectively, while pain was not relieved 16 patients (33%) at medium term (after 12 weeks). Injection of steroid and lignocaine in facet joint was found effective in medium term in 33.3% of patients with chronic low back ache and is alternative to nonoperative treatment.
Lilius et al found tantamount impacts after placebo (saline) and triamcinolone injection. 12 Even small amount of injection was too large in volume to remain confined in small facet joint. In past large volume of injection were used with similar results. Leakage of medication can leads to confounding results like root block and its branches. However, blocking facet joint provide relief of pain in patients resulting in pain relief (50% pain decrease in one third of patients) in patients with chronic lower back ache and can be applied without any side effects.
Authors recommend further larger scale randomized controlled trial on fact injections to document strong positive evidence in favor of our results.
CONCLUSION
Fact joint steroid injection of triamcinolone in combination with lignocaine is effective in reducing chronic backache and discomfort to the patients. Authors recommend this treatment option for all patients with chronic low back ach not responding to conventional methods of pain relief.
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